Skip to Content

Tag: Abbott


Also Noted

FDA approves Libre 2

June 19, 2020HME News Staff

ABBOTT PARK, Ill. - Abbott has received Food and Drug Administration clearance for its Freestyle Libre 2. The Libre 2 continuously transmits glucose data every minute, and users can set the system to send alarms for too-high or too-low readings. Previously, users had to scan the sensor to get a reading. The system, which is offered at the same price point as the previous version of the Freestyle Libre, will become available in the next several weeks. The FreeStyle Libre was approved for Medicare...

Abbott, CGMs, diabetes, FreeStyle Libre


Read Full Articlered right arrow icon

Also Noted

Diabetes research: One Drop, Abbott

February 22, 2019HME News Staff

One Drop has announced the results of a study demonstrating a -0.93 absolute A1c improvement among people with Type 2 diabetes who use its digital therapeutic solution and Afrezza, an inhaled insulin. What's more, A1c improved with the One Drop solution—One Drop Mobile app, One Drop Chrome glucose meter and testing supplies and One Drop Experts coaching—regardless of what type of insulin was used, according to outcomes presented at the 2019 Advanced Technologies & Treatments for Diabetes...

Abbott, diabetes, One Drop, research


Read Full Articlered right arrow icon

Also Noted

Abbott, Novo Nordisk seek to eliminate 'hassle'

February 20, 2019HME News Staff

ABBOTT PARK, Ill. - Abbott and Novo Nordisk have partnered to integrate insulin dose data from Novo Nordisk's connected insulin pens with digital health tools compatible with Abbot's FreeStyle Libre continuous glucose monitoring system. The integration will allow healthcare professionals, caregivers and patients to view glucose and insulin data together to help them make better informed treatment decisions, according to a press release. "It is our aim at Abbott to continuously provide life-changing...

Abbott, FreeStyle Libre, insulin, Novo Nordisk


Read Full Articlered right arrow icon

Also Noted

FDA approves FreeStyle app

November 1, 2018HME News Staff

ABBOTT PARK, Ill. - The FreeStyle LibreLink app has been approved by the U.S. Food and Drug Administration for the iPhone, according to a press release from Abbott. The app allows user to capture and view real-time glucose levels. It also includes a series of in-app reports that visualize blood glucose trends and patterns. The free app will be available for download in the coming weeks and will be able to pair with the FreeStyle Libre or FreeStyle Libre 14 day sensors. The Android version is currently...

Abbott, CGMs, diabetes, FreeStyle LibreLink, Libre


Read Full Articlered right arrow icon

Also Noted

Abbott upgrades FreeStyle Libre

August 1, 2018HME News Staff

ABBOTT PARK, Ill. - The U.S. Food and Drug Administration has approved Abbott's FreeStyle Libre 14-day Flash Glucose Monitoring System. The system has a one-hour warm-up period, compared to 12 hours with the FreeStyle Libre 10-day system, which received FDA approval in September 2017. The Libre is the No. 1 continuous glucose monitoring device in the world, with more than 800,000 users in more than 43 countries, according to a press release. It was approved for Medicare coverage in January.

Abbott, CGMs, diabetes, FreeStyle Libre


Read Full Articlered right arrow icon

Specialty Providers

Abbott Labs, Alere deal moves forward

April 18, 2017HME News Staff

ABBOTT PARK, Ill., and WALTHAM, Mass. - Abbott Laboratories has agreed to buy Alere, but at a lower price than it previously offered.Under amended terms, Abbott will pay $51 per common share to acquire Alere, for a new expected equity value of approximately $5.3 billion, reduced from $5.8 billion, according to a press release.Abbott first announced plans to buy Alere in February 2016. Later that year, however, Abbott filed a complaint in the Delaware Court of Chancery, asking a judge to terminate...

Abbott, Alere, Arriva Medical, diabetes testing, M&A


Read Full Articlered right arrow icon

Also Noted

Abbott plans pediatric tube feeding webinar

February 7, 2014HME News Staff

ABBOTT PARK, Ill. - Abbott is offering a Feb. 20 webinar on pediatric tube feeding for HME providers to gain insight to help them improve service to home enteral patients. Four families will participate in the webinar, sharing their experiences and offering information about HME suppliers, according to a release. The webinar will be recorded for those not available to tune in Feb. 20 at 3 p.m. EST.

Abbott, pediatric tube feeding, Webinar


Read Full Articlered right arrow icon

News

In brief: Report cites spike in PAP use, Inogen sets IPO terms

February 7, 2014HME News Staff

WASHINGTON - The number of beneficiaries receiving PAP devices for a one-year time period grew 13%, while the total number of beneficiaries receiving all DMEPOS items during the same period fell 1%, according to a recently released comparative billing report. Compiled by eGlobal Tech and Palmetto GBA, the report used data from claims processed by the DME MACs between July 2012 and June 2013. They also found allowed charges on PAP devices rose 23%, when allowed charges for all DMEPOS items fell by...

Abbott, ARC Infusion, auto-pap, AxelaCare, BioScrip, BOC, Brent Shafer, cpap, DeVilbiss, FAA


Read Full Articlered right arrow icon